Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Clinical development and evaluation of plasma angiogenesis factors from phase II study of FOLFIRI plus ramucirumab with recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin/fluoropyrimidine (RAINCLOUD): RAINCLOUD-TR.
Authors
Tsuyoshi Hata
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan;
Tsuyoshi Hata , Naotoshi Sugimoto , Nobuyoshi Ohara , Masaaki Miyo , Shinichi Yoshioka , Yoshinori Kagawa , Atsushi Naito , Mitsuyoshi Tei , Hiroshi Tamagawa , Ken Konishi , Genta Sawada , Katsuki Danno , Toshio Shimokawa , Taroh Satoh , Norikatsu Miyoshi , Hidekazu Takahashi , Mamoru Uemura , Kohei Murata , Yuichiro Doki , Hidetoshi Eguchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
Clinical Trial Registration Number
UMIN000028678
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 173)
DOI
10.1200/JCO.2023.41.4_suppl.173
Abstract #
173
Poster Bd #
J13
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Phase II study of FOLFIRI + ramucirumab with recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin / fluoropyrimidine (RAINCLOUD).
First Author: Naotoshi Sugimoto
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Randomized phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922.
First Author: Michael J. Overman
Poster
2019 ASCO Annual Meeting
A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients: The RAMTAS trial of the German AIO (KRK-0316).
First Author: Stefan Kasper
Poster
2019 Gastrointestinal Cancers Symposium
Significance of monitoring plasma vascular endothelial growth factor signals during treatment of colorectal cancer patients.
First Author: Nao Kakizawa